You are here: Home / News / Vivus asks U.S. experts to back its obesity drug

Vivus asks U.S. experts to back its obesity drug

February 22, 2012 By

Related posts:

  1. Vivus obesity drug has safety risks: FDA staff
  2. Vivus obesity drug may get broader label
  3. Modest hope for FDA approval of Vivus obesity drug
  4. Modest hope for FDA approval of Vivus obesity drug
  5. Orexigen, FDA agree on trial design for obesity drug

Filed Under: News Tagged With: ,